Header Logo

Payal Gurnani

Concepts (46)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacists
2
2021
16
0.850
 Why?
Marfan Syndrome
1
2018
4
0.570
 Why?
Drug-Eluting Stents
1
2018
14
0.570
 Why?
Extracorporeal Membrane Oxygenation
1
2018
22
0.560
 Why?
Fluid Therapy
1
2010
25
0.330
 Why?
Shock, Septic
1
2010
59
0.320
 Why?
Practice Guidelines as Topic
1
2010
246
0.290
 Why?
Anti-Bacterial Agents
1
2010
363
0.270
 Why?
Professional Role
2
2021
28
0.210
 Why?
Epoprostenol
1
2021
6
0.180
 Why?
Pulmonary Ventilation
1
2021
9
0.180
 Why?
Nebulizers and Vaporizers
1
2021
21
0.180
 Why?
Antihypertensive Agents
1
2021
40
0.170
 Why?
Hypercalcemia
1
2020
7
0.170
 Why?
Calcitonin
1
2020
14
0.170
 Why?
Diphosphonates
1
2020
15
0.170
 Why?
Intubation, Intratracheal
1
2021
86
0.160
 Why?
Critical Care
1
2021
110
0.160
 Why?
Patient Care Team
1
2021
110
0.160
 Why?
Pandemics
1
2021
203
0.160
 Why?
Neoplasms
1
2020
221
0.140
 Why?
Humans
6
2021
23331
0.130
 Why?
Intensive Care Units
1
2019
247
0.130
 Why?
Emergency Service, Hospital
1
2019
254
0.120
 Why?
Adult
3
2021
7070
0.120
 Why?
Male
4
2021
12629
0.110
 Why?
Resuscitation
1
2010
11
0.080
 Why?
Clinical Protocols
1
2010
54
0.080
 Why?
Evidence-Based Medicine
1
2010
147
0.080
 Why?
Hospital Mortality
1
2010
133
0.080
 Why?
Multivariate Analysis
1
2010
289
0.080
 Why?
Aged
3
2021
7552
0.070
 Why?
Middle Aged
3
2021
8055
0.070
 Why?
Cross Infection
1
2010
297
0.070
 Why?
Time Factors
1
2010
1289
0.060
 Why?
Prospective Studies
1
2010
1523
0.060
 Why?
Female
3
2021
13124
0.060
 Why?
Retrospective Studies
2
2021
3040
0.050
 Why?
Treatment Outcome
1
2010
2988
0.050
 Why?
Reagent Kits, Diagnostic
1
2021
5
0.050
 Why?
Administration, Inhalation
1
2021
37
0.040
 Why?
Dose-Response Relationship, Drug
1
2021
324
0.040
 Why?
Case-Control Studies
1
2021
482
0.040
 Why?
Pharmacy Service, Hospital
1
2019
11
0.040
 Why?
Cost Savings
1
2019
28
0.040
 Why?
Critical Illness
1
2019
110
0.030
 Why?
Gurnani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (46)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_